COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1958: Articles 19571-19580  | Next

Hydroxyzine inhibits SARS-CoV-2 Spike protein binding to ACE2 in a qualitative in vitro assay
Rivas, M. D., Saponi-Cortes, J. M. R., Zamorano, J.
10.1101/2021.01.04.424792 — Posted: 2021-01-05
Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders
Uckun, F., Tuzcu, M., Gitterle, M., Volk, M., Sahin, K.
10.1101/2021.01.03.424883 — Posted: 2021-01-05
Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8
Flower, T. G., Hurley, J. H.
10.1101/2021.01.05.425441 — Posted: 2021-01-05
Synergistic interferon alpha-based drug combinations inhibit SARS-CoV-2 and other viral infections in vitro
Ianevski, A., Yao, R., Zusinaite, E., Lello, L. S., Wang, S., Jo, E., Yang, J., Lysvand, H., Loseth, K., Oksenych, V., Tenson, T., Windisch, M. P., Poranen, M., Nieminen, A. I., Nordbo, S. A., Fenstad, M. H., Grodeland, G., Aukrust, P., Troseid, M., Kantele, A., Merits, A., Bjoras, M., Kainov, D. E.
10.1101/2021.01.05.425331 — Posted: 2021-01-05
SARS-CoV-2 susceptibility of cell lines and substrates commonly used in diagnosis and isolation of influenza and other viruses
Wang, L., Fan, X., Bonenfant, G., Cui, D., Hossain, J., Jiang, N., Larson, G., Currier, M., Liddell, J., Wilson, M., Tamin, A., Harcourt, J., Ciomperlik-Patton, J., Pang, H., Dybdahl-Sissoko, N., Campagnoli, R., Shi, P.-Y., Barnes, J. R., Thornburg, N. J., Wentworth, D. E., Zhou, B.
10.1101/2021.01.04.425336 — Posted: 2021-01-05
The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS)
Vousden, N., Bunch, K., Morris, E., Simpson, N., Gale, C., O'Brien, P., Quigley, M., Brocklehurst, P., Kurinczuk, J. J., Knight, M.
10.1101/2021.01.04.21249195 — Posted: 2021-01-05
Value of radiomics features from adrenal gland and periadrenal fat CT images predicting COVID-19 progression
Zhang, M., Yin, X., Li, W., Zha, Y., Zeng, X., Zhang, X., Cui, J., Tian, J., Wang, R., Liu, C.
10.1101/2021.01.03.21249183 — Posted: 2021-01-05
Prediction of COVID-19 Pandemic of Top Ten Countries in the World Establishing a Hybrid AARNN LTM Model
GAHAN, P., PATTNAIK, M., Nayak, A., Roul, M. K.
10.1101/2020.12.31.20249105 — Posted: 2021-01-05
COVID-19 immunization threshold(s): an analysis
Bautista Balbas, L. A., Gil Conesa, M., Bautista Balbas, B., Alcaide Jimenez, A., Rodriguez Caravaca, G.
10.1101/2021.01.02.20248596 — Posted: 2021-01-05
Similarities and differences of the COVID-19 second surge in Europe and the Northeast United States
Vilar, J., Saiz, L.
10.1101/2021.01.02.21249125 — Posted: 2021-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).